Honda, Satoshi
,
Nishihira, Kensaku
Kojima, Sunao
Takegami, Misa
Asaumi, Yasuhide
Suzuki, Makoto
Kosuge, Masami
Takahashi, Jun
Sakata, Yasuhiko
Takayama, Morimasa
Sumiyoshi, Tetsuya
Ogawa, Hisao
Kimura, Kazuo
Yasuda, Satoshi
Funding for this research was provided by:
Japan Cardiovascular Research Foundation
Article History
First Online: 23 November 2018
Compliance with Ethical Standards
:
: Dr. Yasuda reports remuneration for lectures from Takeda, Daiichi Sankyo, and Bristol-Myers Squibb and trust research/joint research funds from Takeda and Daiichi Sankyo; Dr. Takayama reports lecture fees from Daiichi Sankyo; and Dr. Ogawa reports lecture fees and research grants from AstraZeneca, Bayer, Boehringer Ingelheim,Daiichi Sankyo, Pfizer, and Sanofi. Other authors have no conflict of interest.
: This study has been conducted in accordance with the ethical guidelines for medical research on humans laid out in the Declaration of Helsinki. This research protocol was designed by the authors and approved by the Institutional Review Board of the National Cerebral and Cardiovascular Center and local ethics committees or local institutional review board at each study site. Although informed consent was not obtained due to the observational nature of this registry, details about the study were posted on a website and at the study sites (opt-out) to inform the subjects of the content and timeline of the study and to ensure that they have the opportunity to refuse participation in this registry. In addition, the research secretariat confirmed compliance with opt-out procedures at each study site. This study is registered with the Japanese UMIN Clinical Trials Registry (UMIN000019479).